BiotechCorp Annual Report 2007 - Malaysian Biotechnology ...

42
During the financial year ended 31 December 2005, the Company convened a total of three meetings and the respective Director’s
attendance is as follows:
No. Name No. Of Meetings Attended
1 YBhg Tan Sri Datuk Dr Ahmad Zaharudin bin Idrus 3
2 YBhg Dato’ Iskandar Mizal bin Mahmood 3
Supply of Information
All Directors are provided with reports on major operational, financial and corporate issues prior to the Board Meetings. Agenda and
papers on specific subjects are sent to members of the Board in advance to ensure there is sufficient time for the Directors to obtain
further explanations where necessary and to facilitate informed decision-making process.
Appointment and Re-election of Directors
In accordance with the Articles of Association of the Company, at every Annual General Meeting (AGM), one-third of the Directors
shall retire from office but shall be eligible for re-election. The Articles also provide that Directors appointed during the year by the
Board shall hold office until the next following AGM, and shall be eligible for re-election.
Board Committees
The Board has appointed Board committees, which operates within clearly defined terms of reference. Committees of the Board
include the following:
(a) Audit Committee (AC)
The AC comprises the following:
i) Dato’ Abdul Hanan bin Alang Endut – Chairman
ii) Cik Nelleita binti Omar
iii) Mr David Ho Sue San
The AC met once during the financial year ended 31 December 2006 and once during the financial year ended 31 December
2007. All members attended both the meetings held.
(b) Nomination and Remuneration Committee (NRC)
The NRC comprises the following:
i) Tan Sri Datuk Dr Ahmad Zaharudin bin Idrus – Chairman
ii) Tan Sri Datuk Dr Haji Mohamed Ismail bin Merican
iii) Cik Nelleita binti Omar
iv) Puan Zaiton binti Jamaluddin
The NRC met twice during the financial year ended 2006 and three times during the financial year ended 2007.
(c) Cluster Working Groups (CWGs)
Main Objective:
The Board of Directors had, on 10 February 2006, resolved for the establishment of CWGs comprising representatives of
BiotechCorp and its stakeholders (public and private sectors). Each CWG is headed by a member of the Board, and serves as the
forum for BiotechCorp and its stakeholders to discuss issues relating to the implementation of the National Biotechnology Policy.
The areas covered include:
CWG on Agricultural Biotechnology CWG on Human Capital Development
CWG on Healthcare Biotechnology CWG on Funding Support
CWG on Industrial Biotechnology